Russo TA - Search Results

1

Uropathogenic Escherichia coli as agents of diverse non-urinary tract extraintestinal infections.

Johnson JR, Russo TA. Johnson JR, et al. Among authors: russo ta. J Infect Dis. 2002 Sep 15;186(6):859-64. doi: 10.1086/342490. Epub 2002 Aug 20. J Infect Dis. 2002. PMID: 12198625

2

Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans.

Colpan A, Johnston B, Porter S, Clabots C, Anway R, Thao L, Kuskowski MA, Tchesnokova V, Sokurenko EV, Johnson JR; VICTORY (Veterans Influence of Clonal Types on Resistance: Year 2011) Investigators. Colpan A, et al. Clin Infect Dis. 2013 Nov;57(9):1256-65. doi: 10.1093/cid/cit503. Epub 2013 Aug 6. Clin Infect Dis. 2013. PMID: 23926176 Free PMC article.

3

Extraintestinal pathogenic Escherichia coli: "the other bad E coli".

Johnson JR, Russo TA. Johnson JR, et al. Among authors: russo ta. J Lab Clin Med. 2002 Mar;139(3):155-62. doi: 10.1067/mlc.2002.121550. J Lab Clin Med. 2002. PMID: 11944026 Review.

4

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem.

Russo TA, Johnson JR. Russo TA, et al. Microbes Infect. 2003 Apr;5(5):449-56. doi: 10.1016/s1286-4579(03)00049-2. Microbes Infect. 2003. PMID: 12738001 Free article. Review.

5

Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Johnson JR, Gajewski A, Lesse AJ, Russo TA. Johnson JR, et al. Among authors: russo ta. J Clin Microbiol. 2003 Dec;41(12):5798-802. doi: 10.1128/JCM.41.12.5798-5802.2003. J Clin Microbiol. 2003. PMID: 14662987 Free PMC article.

6

Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli.

Johnson JR, Russo TA. Johnson JR, et al. Among authors: russo ta. Int J Med Microbiol. 2005 Oct;295(6-7):383-404. doi: 10.1016/j.ijmm.2005.07.005. Int J Med Microbiol. 2005. PMID: 16238015 Review.

7

Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development.

Russo TA, Johnson JR. Russo TA, et al. Expert Rev Vaccines. 2006 Feb;5(1):45-54. doi: 10.1586/14760584.5.1.45. Expert Rev Vaccines. 2006. PMID: 16451107 Review.

8

OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsis.

Johnson JR, Russo TA, Drawz SM, Clabots C, Olson R, Kuskowski MA, Rosen H. Johnson JR, et al. Among authors: russo ta. Microb Pathog. 2013 Nov;64:1-5. doi: 10.1016/j.micpath.2013.07.001. Epub 2013 Jul 12. Microb Pathog. 2013. PMID: 23850958

9

Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.

Russo TA, Spellberg B, Johnson JR. Russo TA, et al. J Infect Dis. 2016 Mar 15;213(6):901-3. doi: 10.1093/infdis/jiv533. Epub 2015 Nov 12. J Infect Dis. 2016. PMID: 26563238 Free PMC article. Review.

10

Molecular Epidemiology of Extraintestinal Pathogenic Escherichia coli.

Johnson JR, Russo TA. Johnson JR, et al. Among authors: russo ta. EcoSal Plus. 2018 Apr;8(1). doi: 10.1128/ecosalplus.ESP-0004-2017. EcoSal Plus. 2018. PMID: 29667573 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters